[{"_id":"551f89b631cae9239deb1eea","会社名":"ロート製薬(株)【4527】","証券コード":"4527","決算期":"2014年3月期","会計方式":"日本方式","決算発表日":"2014年5月14日","決算月数":"12か月","売上高":"143,822百万円","営業利益":"16,821百万円","経常利益":"17,100百万円","当期利益":"8,947百万円","EPS（一株当たり利益）":"77.15円","調整一株当たり利益":"76.82円","BPS（一株当たり純資産）":"861.49円","総資産":"162,249百万円","自己資本":"97,680百万円","資本金":"6,411百万円","有利子負債":"9,882百万円","自己資本比率":"60.2%","ROA（総資産利益率）":"5.72%","ROE（自己資本利益率）":"9.39%","総資産経常利益率":"10.93%","__v":0,"日付":"2015-04-04T06:50:30.630Z"},{"_id":"551f89b631cae9239deb1eeb","会社名":"ロート製薬(株)【4527】","証券コード":"4527","決算期":"2013年3月期","会計方式":"日本方式","決算発表日":"2013年5月15日","決算月数":"12か月","売上高":"129,146百万円","営業利益":"14,380百万円","経常利益":"14,730百万円","当期利益":"8,087百万円","EPS（一株当たり利益）":"68.78円","調整一株当たり利益":"68.49円","BPS（一株当たり純資産）":"789.83円","総資産":"150,643百万円","自己資本":"92,878百万円","資本金":"6,408百万円","有利子負債":"7,189百万円","自己資本比率":"61.7%","ROA（総資産利益率）":"5.64%","ROE（自己資本利益率）":"9.21%","総資産経常利益率":"10.28%","__v":0,"日付":"2015-04-04T06:50:30.630Z"},{"_id":"551f89b631cae9239deb1eec","会社名":"ロート製薬(株)【4527】","証券コード":"4527","決算期":"2012年3月期","会計方式":"日本方式","決算発表日":"2012年5月11日","決算月数":"12か月","売上高":"120,292百万円","営業利益":"13,624百万円","経常利益":"13,684百万円","当期利益":"8,184百万円","EPS（一株当たり利益）":"69.60円","調整一株当たり利益":"69.31円","BPS（一株当たり純資産）":"703.93円","総資産":"136,008百万円","自己資本":"82,775百万円","資本金":"6,405百万円","有利子負債":"8,438百万円","自己資本比率":"60.9%","ROA（総資産利益率）":"6.24%","ROE（自己資本利益率）":"10.24%","総資産経常利益率":"10.43%","__v":0,"日付":"2015-04-04T06:50:30.631Z"}]